Goat F(ab')2 Anti-Human IgG - Fc (PE), pre-adsorbed
4
(1 Review)
|
(15 Publications)
Goat F(ab')2 Anti-Human IgG - Fc (PE) is a pre-adsorbed secondary antibody with a maximum absorption wavelength of 480;565nm and a maximum emission wavelength of 578nm. Suitable for Flow Cytometry.
- Preadsorbed to prevent cross-reactivity and reduce background staining
- F(ab) fragment secondary antibodies eliminate non-specific binding between Fc regions of antibodies and Fc receptors on immune cells
- Cited in over 10 publications
View Alternative Names
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1
- Flow Cyt
Unknown
Flow Cytometry - Goat F(ab')2 Anti-Human IgG - Fc (PE), pre-adsorbed (AB98596)
Flow Cytometry - Goat F(ab')2 Anti-Human IgG - Fc (PE), pre-adsorbed (ab98596)
CHO cell line expressing membrane bound human TNFα (stable transfectants) was incubated with 10 μg/ml Remicade (anti-human TNFa monoclonal antibody) for 1 h in 4°C. The unbound antibody was washed off by centrifugation (300x g for 5 min) and binding of remicade was detected with PE Goat F(ab)2 anti-hIgG Fc (ab98596) – 1 : 100 (5 μg/ml), 30 min incubation in 4°C. The cells were washed twice in FACS buffer (2.5% BSA, 0.1% sodium azide in dPBS), before flow cytometric analysis.
PE goat F(ab)2 anti-hIgG detected binding of remicade to TNFα CHO cell line giving strong positive signal, however there was some non-specific binding to the cells alone. Further optimisation of the reagent concentration and washing procedure should improve the background signal.
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Target data
Additional targets
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 15:1439418 PubMed39267766
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 84:1680-1698 PubMed38501978
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed37737226
2023
Applications
Unspecified application
Species
Unspecified reactive species
Phytomedicine : international journal of phytotherapy and phytopharmacology 118:154942 PubMed37421767
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 10: PubMed35728874
2022
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:103720 PubMed35005526
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 35:109142 PubMed34010642
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:5597 PubMed33154358
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 32:107918 PubMed32668215
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 37:850-866.e7 PubMed32442402
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com